Effectiveness and Safety of Single Lower Limb Rehabilitation Training Robot in Stroke Patients With Hemiplegia

By collecting the movement gait information of the patient's healthy side limb, judging the patient's movement intention, analyzing and learning the gait characteristics of the patient's healthy side, so as to drive the movement of the single lower limb rehabilitation training robot and drive the patient's affected side limb to carry out the rehabilitation training suitable for the healthy side limb, which can enable the patient to complete the normal walking process and achieve the purpose of auxiliary rehabilitation. Through long-term walking rehabilitation, patients can gradually recover their normal walking gait.

Inclusion criteria

• understand the whole process of the experiment, voluntarily participate and sign the informed consent;

• 18-75 years old for both sexes;

• Stable vital signs, stable condition, tolerance to low-intensity sitting and standing training;

④ Weight ≤ 100kg, height 1.50M ~ 1.90m;

⑤ Patients with stroke hemiplegia diagnosed as the first onset, including cerebral infarction and intracerebral hemorrhage, the course of disease is within one month after the onset;

⑥ One level of sitting or standing balance, able to wear a single lower limb rehabilitation training robot with the help of medical staff;

⑦ The passive range of motion of hip and knee is not significantly limited, and the passive range of ankle can be kept in neutral position.

Exclusion criteria

• The range of motion of the joint is severely limited and the walking movement is limited;

• Skin injury or infection of the lower limb in contact with the robot;

• History of unstable angina pectoris, severe arrhythmia and other heart diseases;

④ History of severe chronic obstructive pulmonary disease;

⑤ Other contraindications or complications that may affect walking training;

⑥ Pregnant women, women preparing for pregnancy or lactation;

⑦ Those who participated in any clinical trial within 1 month before enrollment;

⑧ Other circumstances that the researcher believes cannot participate in the clinical trial.